nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Future treatments for Sjögren's syndrome
|
Pers, Jacques-Olivier |
|
2016 |
45 |
6P2 |
p. e193-e200 nvt p. |
artikel |
2 |
Innovations in autoimmune diseases
|
Guillevin, Loïc |
|
2016 |
45 |
6P2 |
p. e157-e158 nvt p. |
artikel |
3 |
New therapeutic approaches for ANCA-associated vasculitides
|
Chaigne, Benjamin |
|
2016 |
45 |
6P2 |
p. e171-e178 nvt p. |
artikel |
4 |
New therapeutic approaches in rheumatoid arthritis
|
van Vollenhoven, Ronald F. |
|
2016 |
45 |
6P2 |
p. e179-e192 nvt p. |
artikel |
5 |
Stem cell transplantation and mesenchymal cells to treat autoimmune diseases
|
Tyndall, Alan |
|
2016 |
45 |
6P2 |
p. e159-e169 nvt p. |
artikel |
6 |
Therapeutic innovations in endocrine diseases – Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?
|
Reznik, Yves |
|
2016 |
45 |
6P2 |
p. e205-e210 nvt p. |
artikel |
7 |
Therapeutic innovations in endocrine diseases – Part 1: New medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome)
|
Bertagna, Xavier |
|
2016 |
45 |
6P2 |
p. e201-e204 nvt p. |
artikel |
8 |
Therapeutic innovations in endocrine diseases – Part 4 : Pasireotide: Long-acting release somatostatin analogue
|
Wémeau, Jean-Louis |
|
2016 |
45 |
6P2 |
p. e217-e220 nvt p. |
artikel |
9 |
Therapeutic innovations in endocrine diseases – Part 5: Rituximab and graves’ orbitopathy
|
Ladsous, Miriam |
|
2016 |
45 |
6P2 |
p. e221-e224 nvt p. |
artikel |
10 |
Therapeutic innovations in endocrine diseases – part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas
|
Lasolle, Hélène |
|
2016 |
45 |
6P2 |
p. e211-e216 nvt p. |
artikel |